GSK3B and familial pancreatic carcinoma: Moreover, a combination of GSK-3β inhibitors, such as AR-A014418 and 9-ING-41, with chemotherapeutic drugs had a synergistic effect in killing pancreatic cancer cells in vitro and in vivo in a xenograft model (Ding and Billadeau, 2020).